Abstract
The physiological performance of an organ depends on an interplay between changes in cellular function and organ size, determined by cell growth, proliferation and death. Nowhere is this more evident than in the endocrine pancreas, where disturbances in function or mass result in severe disease. Recently, the insulin signal-transduction pathway has been implicated in both the regulation of hormone secretion from β cells in mammals as well as the determination of cell and organ size in Drosophila melanogaster. A prominent mediator of the actions of insulin and insulin-like growth factor 1 (IGF-1) is the 3′-phosphoinositide–dependent protein kinase Akt, also known as protein kinase B (PKB). Here we report that overexpression of active Akt1 in the mouse β cell substantially affects compartment size and function. There was a significant increase in both β-cell size and total islet mass, accompanied by improved glucose tolerance and complete resistance to experimental diabetes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Mauricio, D. & Mandrup-Poulsen, T. Apoptosis and the pathogenesis of IDDM: A question of life and death. Diabetes 47, 1537–1543 (1998).
Pick, A. et al. Role of apoptosis in failure of β-cell mass compensation for insulin resistance and β-cell defects in the male Zucker diabetic fatty rat. Diabetes 47, 358–364 (1998).
Kulkarni, R.N. et al. Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96, 329–339 (1999).
Withers, D.J. et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391, 900–904 (1998).
Coffer, P.J., Jin, J. & Woodgett, J.R. Protein kinase B (c-Akt): A multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem. J. 335, 1–13 (1998).
Staveley, B.E. et al. Genetic analysis of protein kinase B (AKT) in Drosophila. Curr. Biol. 8, 599–602 (1998).
Verdu, J., Buratovich, M.A., Wilder, E.L. & Birnbaum, M.J. Cell-autonomous regulation of cell and organ growth in Drosophila by Akt/PKB. Nature Cell Biol. 1, 500–506 (1999).
Paradis, S. & Ruvkun, G. Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes Dev. 12, 2488–2498 (1998).
Kohn, A.D., Takeuchi, F. & Roth, R.A. Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation. J. Biol. Chem. 271, 21920–21926 (1996).
Alessi, D.R. et al. Mechanism of activation of protein kinase B by insulin and IGF-1. Embo J. 15, 6541–6551 (1996).
Like, A.A. & Rossini, A.A. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193, 415–417 (1976).
O'Brien, B.A., Harmon, B.V., Cameron, D.P. & Allan, D.J. β-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model. J. Pathol. 178, 176–181 (1996).
Edgar, B.A. From small flies come big discoveries about size control. Nature Cell Biol. 1, E191–E193 (1999).
Chen, C., Jack, J. & Garofalo, R.S. The Drosophila insulin receptor is required for normal growth. Endocrinology 137, 846–856 (1996).
Bohni, R. et al. Autonomous control of cell and organ size by CHICO, a Drosophila homolog of vertebrate IRS1-4. Cell 97, 865–875 (1999).
Weinkove, D., Neufeld, T.P., Twardzik, T., Waterfield, M.D. & Leevers, S.J. Regulation of imaginal disc cell size, cell number and organ size by Drosophila class I(A) phosphoinositide 3-kinase and its adaptor. Curr. Biol. 9, 1019–1029 (1999).
Montagne, J. et al. Drosophila S6 kinase: a regulator of cell size [see comments]. Science 285, 2126–2129 (1999).
Scott, P.H., Brunn, G.J., Kohn, A.D., Roth, R.A., Lawrence, J.C., Jr. Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway. Proc. Natl. Acad. Sci. USA 95, 7772–7777 (1998).
Heyner, S. & Garside, W.T. Biological actions of IGFs in mammalian development. Bioessays 16, 55–57 (1994).
Le Roith, D. Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors. N. Engl. J. Med. 336, 633–640 (1997).
Shioi, T. et al. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. Embo J. 19, 2537–2548 (2000).
Shima, H. et al. Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase. Embo J. 17, 6649–6659 (1998).
Pende, M. et al. Hypoinsulinaemia, glucose intolerance and diminished β-cell size in S6K1-deficient mice. Nature 408, 994–997. (2000).
Withers, D.J. et al. Irs-2 coordinates Igf-1 receptor-mediated β-cell development and peripheral insulin signalling. Nature Genet. 23, 32–40 (1999).
Finegood, D.T., Scaglia, L. & Bonner-Weir, S. Dynamics of β-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. Diabetes 44, 249–256 (1995).
Hanahan, D. Heritable formation of pancreatic β-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 315, 115–122 (1985).
Kohn, A.D., Kovacina, K.S. & Roth, R.A. Insulin stimulates the kinase activity of RAC-PK, a pleckstrin homology domain containing ser/thr kinase. Embo J. 14, 4288–4295 (1995).
Summers, S.A., Whiteman, E.L., Cho, H., Lipfert, L. & Birnbaum, M.J. Differentiation-dependent suppression of platelet-derived growth factor signaling in cultured adipocytes. J. Biol. Chem. 274, 23858–23867 (1999).
Montana, E., Bonner-Weir, S. & Weir, G.C. β-cell mass and growth after syngeneic islet cell transplantation in normal and streptozocin diabetic C57BL/6 mice. J. Clin. Invest. 91, 780–787 (1993).
Pontoglio, M. et al. Defective insulin secretion in hepatocyte nuclear factor 1α-deficient mice. J. Clin. Invest. 101, 2215–2222 (1998).
Acknowledgements
The authors gratefully acknowledge services provided by the Center for Molecular Studies in Digestive and Liver Disease (Grant P30DK50306) and the Penn Diabetes Center (Grant DK19525). We thank B. Wolf, R. Ahima, and F. Matschinsky for helpful discussions and advice; and Q. Chu for technical assistance. This work was supported by grants from the National Institute of Health (R01 DK56886).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tuttle, R., Gill, N., Pugh, W. et al. Regulation of pancreatic β-cell growth and survival by the serine/threonine protein kinase Akt1/PKBα. Nat Med 7, 1133–1137 (2001). https://doi.org/10.1038/nm1001-1133
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm1001-1133
This article is cited by
-
Dysregulated lncRNAs regulate human umbilical cord mesenchymal stem cell differentiation into insulin-producing cells by forming a regulatory network with mRNAs
Stem Cell Research & Therapy (2024)
-
Inhibition mechanism of MRTX1133 on KRASG12D: a molecular dynamics simulation and Markov state model study
Journal of Computer-Aided Molecular Design (2023)
-
The effect and mechanism of Jiao-tai-wan in the treatment of diabetes mellitus with depression based on network pharmacology and experimental analysis
Molecular Medicine (2021)
-
New-found brake calibrates insulin action in β-cells
Nature (2021)
-
The parasite-derived peptide FhHDM-1 activates the PI3K/Akt pathway to prevent cytokine-induced apoptosis of β-cells
Journal of Molecular Medicine (2021)